Literature DB >> 1645563

DNA interstrand crosslinking and sequence selectivity of dimethanesulphonates.

M Ponti1, R L Souhami, B W Fox, J A Hartley.   

Abstract

Members of the homologous series of alkanediol dimethanesulphonates of general formula H3C.SO2O.(CH2)n.O.SO2.CH3 have been tested for their ability to produce DNA interstrand crosslinking and DNA sequence selectivity of guanine-N7 alkylation. In a sensitive crosslinking gel assay the efficiency of DNA interstrand crosslink formation, dependent on the ability of the alkylating moiety to span critical nucleophilic distances within the DNA, was found at 6 h to be 1,6-hexanediol dimethanesulphonate (Hexa-DMS) (n = 6) greater than methylene dimethanesulphonate (MDMS) (n = 1) greater than 1,8-octanediol dimethanesulphonate (Octa-DMS) (n = 8) greater than Busulphan (n = 4). The DNA interstrand crosslinking produced by MDMS was not due to either of its hydrolysis products, formaldehyde or methanesulphonic acid (MSA). In contrast the extent of monoalkylation at guanine-N7 as determined by a modified DNA sequencing technique was found to be Busulphan much greater than Hexa-DMS = Octa-DMS, with a sequence selectivity somewhat less than that of other chemotherapeutic alkylating agents such as nitrogen mustards. MDMS at high levels induced a non-specific depurination as a result of the reduction in pH resulting from MSA release. More strikingly MDMS (and MSA) produced a single strong site of guanine reaction (depurination) in a guanine-rich 276 base pair fragment of pBR322 DNA in the sequence of 5'-ATGGTGG-3'. This was observed when non-specific depurination was negligible and was not seen with formic acid. Thus structurally similar alkylating agents can differ in their type and extent of DNA monoalkylation and interstrand crosslinking, and in some cases (e.g. MDMS/MSA) produce reactions with a high degree of selectivity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645563      PMCID: PMC1972377          DOI: 10.1038/bjc.1991.166

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  The biological significance of the changes produced in the deoxyribonucleic acid of cells treated with radiomimetic alkylating agents.

Authors:  P ALEXANDER; J T LETT
Journal:  Biochem Pharmacol       Date:  1960-08       Impact factor: 5.858

2.  IN VIVO EFFECTS OF METHYLENE DIMETHANESULPHONATE ON PROLIFERATING CELL SYSTEMS.

Authors:  B W FOX; H JACKSON
Journal:  Br J Pharmacol Chemother       Date:  1965-02

3.  Myleran in chronic myeloid leukaemia; results of treatment.

Authors:  D A GALTON
Journal:  Lancet       Date:  1953-01-31       Impact factor: 79.321

4.  An agarose gel method for the determination of DNA interstrand crosslinking applicable to the measurement of the rate of total and "second-arm" crosslink reactions.

Authors:  J A Hartley; M D Berardini; R L Souhami
Journal:  Anal Biochem       Date:  1991-02-15       Impact factor: 3.365

5.  The reaction of mono- and di-functional alkylating agents with nucleic acids.

Authors:  P Brookes; P D Lawley
Journal:  Biochem J       Date:  1961-09       Impact factor: 3.857

6.  Mechanisms of DNA sequence selective alkylation of guanine-N7 positions by nitrogen mustards.

Authors:  K W Kohn; J A Hartley; W B Mattes
Journal:  Nucleic Acids Res       Date:  1987-12-23       Impact factor: 16.971

7.  DNA sequence selectivity of guanine-N7 alkylation by three antitumor chloroethylating agents.

Authors:  J A Hartley; N W Gibson; K W Kohn; W B Mattes
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

8.  Isolation and characterization of proteins cross-linked to DNA by the antitumor agent methylene dimethanesulfonate and its hydrolytic product formaldehyde.

Authors:  P M O'Connor; B W Fox
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

9.  Comparative studies of DNA cross-linking reactions following methylene dimethanesulphonate and its hydrolytic product, formaldehyde.

Authors:  P M O'Connor; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

10.  Busulfan (1, 4-dimethanesulfonyloxybutane, myleran); summary of clinical results.

Authors:  D A GALTON; M TILL; E WILTSHAW
Journal:  Ann N Y Acad Sci       Date:  1958-04-24       Impact factor: 5.691

View more
  6 in total

Review 1.  A review of the role of the sequence-dependent electrostatic landscape in DNA alkylation patterns.

Authors:  Barry Gold; Luis M Marky; Michael P Stone; Loren D Williams
Journal:  Chem Res Toxicol       Date:  2006-11       Impact factor: 3.739

2.  The Myeloablative Drug Busulfan Converts Cysteine to Dehydroalanine and Lanthionine in Redoxins.

Authors:  Michele Scian; Miklos Guttman; Samantha D Bouldin; Caryn E Outten; William M Atkins
Journal:  Biochemistry       Date:  2016-08-11       Impact factor: 3.162

3.  The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling.

Authors:  Benigno C Valdez; Yang Li; David Murray; Richard E Champlin; Borje S Andersson
Journal:  Biochem Pharmacol       Date:  2010-10-08       Impact factor: 5.858

4.  Investigation of fungal biomolecules after Low Earth Orbit exposure: a testbed for the next Moon missions.

Authors:  Alessia Cassaro; Claudia Pacelli; Mickael Baqué; Barbara Cavalazzi; Giorgio Gasparotto; Raffaele Saladino; Lorenzo Botta; Ute Böttger; Elke Rabbow; Jean-Pierre de Vera; Silvano Onofri
Journal:  Environ Microbiol       Date:  2022-04-22       Impact factor: 5.476

Review 5.  DNA damage and repair in human cancer: molecular mechanisms and contribution to therapy-related leukemias.

Authors:  Ida Casorelli; Cecilia Bossa; Margherita Bignami
Journal:  Int J Environ Res Public Health       Date:  2012-07-27       Impact factor: 3.390

6.  Insights into the Survival Capabilities of Cryomyces antarcticus Hydrated Colonies after Exposure to Fe Particle Radiation.

Authors:  Claudia Pacelli; Cassaro Alessia; Loke M Siong; Aureli Lorenzo; Ralf Moeller; Akira Fujimori; Shuryak Igor; Onofri Silvano
Journal:  J Fungi (Basel)       Date:  2021-06-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.